Over the latest trailing 12-month period, price cagr is +33.84%. The comparable SPY value is +18.07%. Year-to-date price return is +16.66%. Price CAGR uses adjusted close price history and excludes dividends.
Over longer horizons, Price CAGR averages 15.52% over 3 years and 22.55% over 5 years; the trailing 12 months came in at +33.84%. The price CAGR (Compound Annual Growth Rate) shows how the company's stock price has grown over various time periods. This measures pure price appreciation without including dividends.
Vertex Pharmaceuticals Incorporated (VRTX)
Price growth vs the same quarter one year earlier, last 40 quarters.
Quarter-end adjusted closing prices; the newest quarter may be quarter-to-date.
| Year | Start Price | End Price | Change | % Change |
|---|---|---|---|---|
| 2026 (YTD) | $453.36 | $528.9 | +$75.54 | +16.66% |
| 2025 | $402.7 | $453.36 | +$50.66 | +12.58% |
| 2024 | $406.89 | $402.7 | −$4.19 | -1.03% |
| 2023 | $288.78 | $406.89 | +$118.11 | +40.90% |
| 2022 | $219.6 | $288.78 | +$69.18 | +31.50% |
| 2021 | $236.34 | $219.6 | −$16.74 | -7.08% |
| 2020 | $218.95 | $236.34 | +$17.39 | +7.94% |
| 2019 | $165.71 | $218.95 | +$53.24 | +32.13% |
| 2018 | $149.86 | $165.71 | +$15.85 | +10.58% |
| 2017 | $73.67 | $149.86 | +$76.19 | +103.42% |
| 2016 | $125.83 | $73.67 | −$52.16 | -41.45% |
| 2015 | $118.8 | $125.83 | +$7.03 | +5.92% |
| 2014 | $74.3 | $118.8 | +$44.5 | +59.89% |
| 2013 | $41.9 | $74.3 | +$32.4 | +77.33% |
| 2012 | $33.21 | $41.9 | +$8.69 | +26.17% |
| 2011 | $35.03 | $33.21 | −$1.82 | -5.20% |
| 2010 | $42.85 | $35.03 | −$7.82 | -18.25% |
| 2009 | $30.38 | $42.85 | +$12.47 | +41.05% |
| 2008 | $23.23 | $30.38 | +$7.15 | +30.78% |
| 2007 | $37.42 | $23.23 | −$14.19 | -37.92% |
| 2006 | $27.67 | $37.42 | +$9.75 | +35.24% |
| 2005 | $10.57 | $27.67 | +$17.1 | +161.78% |
| 2004 | $10.35 | $10.57 | +$0.22 | +2.13% |
| 2003 | $15.85 | $10.35 | −$5.5 | -34.70% |
| 2002 | $24.59 | $15.85 | −$8.74 | -35.54% |
| 2001 | $71.5 | $24.59 | −$46.91 | -65.61% |
| 2000 | $17.5 | $71.5 | +$54 | +308.57% |
| 1999 | $14.88 | $17.5 | +$2.63 | +17.65% |
| 1998 | $16.5 | $14.88 | −$1.63 | -9.85% |
| 1997 | $20.13 | $16.5 | −$3.63 | -18.01% |
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q3 2026 (QTD) | $528.90 | +7.6% | +38.1% |
| Q2 2026 | $491.34 | +8.0% | +9.6% |
| Q1 2026 | $454.97 | -0.3% | -7.7% |
| Q4 2025 | $456.20 | +19.1% | +12.6% |
| Q3 2025 | $383.12 | -14.6% | -16.7% |
| Q2 2025 | $448.40 | -9.0% | -4.3% |
| Q1 2025 | $492.69 | +21.6% | +19.6% |
| Q4 2024 | $405.27 | -11.9% | -1.0% |
| Q3 2024 | $460.00 | -1.9% | +31.6% |
| Q2 2024 | $468.71 | +13.7% | +35.0% |
| Q1 2024 | $412.11 | +0.7% | +31.1% |
| Q4 2023 | $409.27 | +17.1% | +39.6% |
| Q3 2023 | $349.65 | +0.7% | +20.8% |
| Q2 2023 | $347.12 | +10.4% | +23.2% |
| Q1 2023 | $314.39 | +7.2% | +21.9% |
| Q4 2022 | $293.23 | +1.3% | +31.9% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier. The newest quarter is in progress (quarter-to-date).
